Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC)
CUSIP: 761330109
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 104,661,494
- Total 13F shares
- 81,357,406
- Share change
- -1,678,380
- Total reported value
- $209,091,543
- Put/Call ratio
- 35%
- Price per share
- $2.57
- Number of holders
- 167
- Value change
- -$16,845,100
- Number of buys
- 86
- Number of sells
- 80
Quarterly Holders Quick Answers
What is CUSIP 761330109?
CUSIP 761330109 identifies RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 761330109:
Top shareholders of RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Capital World Investors |
13F
|
Company |
13%
|
13,945,535
|
$68,612,032 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
7%
|
7,312,479
|
$35,977,397 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
6%
|
6,283,407
|
$30,914,364 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.2%
|
5,398,406
|
$26,560,157 | — | 31 Mar 2024 | |
| Palo Alto Investors LP |
13F
|
Company |
5%
|
5,248,004
|
$25,820,180 | — | 31 Mar 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
3.7%
|
3,884,819
|
$19,113,309 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
3%
|
3,153,123
|
$15,513,366 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
2.9%
|
3,019,342
|
$14,855,162 | — | 31 Mar 2024 | |
| Rubric Capital Management LP |
13F
|
Company |
2.5%
|
2,656,847
|
$13,071,687 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.3%
|
2,358,777
|
$11,605,183 | — | 31 Mar 2024 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
1.9%
|
1,976,342
|
$9,723,603 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
1,970,838
|
$9,697,712 | — | 31 Mar 2024 | |
| CIBC Asset Management Inc |
13F
|
Company |
1.7%
|
1,740,518
|
$8,563,349 | — | 31 Mar 2024 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
1,600,000
|
$7,872,000 | — | 31 Mar 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
1.5%
|
1,564,702
|
$7,698,334 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.2%
|
1,203,904
|
$5,923,213 | — | 31 Mar 2024 | |
| BAMCO INC /NY/ |
13F
|
Company |
0.98%
|
1,023,663
|
$5,036,422 | — | 31 Mar 2024 | |
| Aubrey Rankin |
3/4/5
|
Director |
—
class O/S missing
|
570,004
|
$4,257,930 | — | 15 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.83%
|
865,229
|
$4,256,927 | — | 31 Mar 2024 | |
| Opaleye Management Inc. |
13F
|
Company |
0.75%
|
785,000
|
$3,862,200 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.75%
|
781,223
|
$3,843,617 | — | 31 Mar 2024 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.71%
|
746,139
|
$3,671,004 | — | 31 Mar 2024 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.67%
|
701,707
|
$3,452,398 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.67%
|
700,050
|
$3,444,246 | — | 31 Mar 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.59%
|
622,126
|
$3,060,860 | — | 31 Mar 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.57%
|
600,000
|
$2,952,000 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.52%
|
543,449
|
$2,673,769 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.48%
|
504,676
|
$2,483,005 | — | 31 Mar 2024 | |
| EULAV Asset Management |
13F
|
Company |
0.48%
|
500,000
|
$2,460,000 | — | 31 Mar 2024 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.45%
|
468,871
|
$2,306,845 | — | 31 Mar 2024 | |
| Essex Woodlands Management, Inc. |
13F
|
Company |
0.44%
|
457,085
|
$2,248,858 | — | 31 Mar 2024 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.43%
|
450,000
|
$2,214,000 | — | 31 Mar 2024 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.43%
|
445,387
|
$2,192,000 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.36%
|
373,700
|
$1,839,000 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.34%
|
352,042
|
$1,732,047 | — | 31 Mar 2024 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.31%
|
329,267
|
$1,619,994 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.29%
|
304,564
|
$1,498,455 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.28%
|
298,110
|
$1,466,701 | — | 31 Mar 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.28%
|
288,726
|
$1,420,532 | — | 31 Mar 2024 | |
| DCF Advisers, LLC |
13F
|
Company |
0.25%
|
263,372
|
$1,295,790 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.25%
|
257,397
|
$1,266,393 | — | 31 Mar 2024 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.24%
|
254,667
|
$1,252,962 | — | 31 Mar 2024 | |
| CM Management, LLC |
13F
|
Company |
0.24%
|
250,000
|
$1,230,000 | — | 31 Mar 2024 | |
| MOORE CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.24%
|
250,000
|
$1,230,000 | — | 31 Mar 2024 | |
| AlphaCentric Advisors LLC |
13F
|
Company |
0.23%
|
245,000
|
$1,205,400 | — | 31 Mar 2024 | |
| Mirae Asset Global Investments Co., Ltd. |
13F
|
Company |
0.04%
|
37,618
|
$1,111,531 | — | 31 Mar 2024 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC |
13F
|
Company |
0.21%
|
220,160
|
$1,083,187 | — | 31 Mar 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.2%
|
211,695
|
$1,041,539 | — | 31 Mar 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.19%
|
200,000
|
$984,000 | — | 31 Mar 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.19%
|
198,846
|
$978,322 | — | 31 Mar 2024 |
Institutional Holders of Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) as of Q2 2024
As of 30 Jun 2024,
Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) was held by
167 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
81,357,406 shares.
The largest 10 holders included
Capital World Investors, BlackRock Inc., FRANKLIN RESOURCES INC, VANGUARD GROUP INC, Palo Alto Investors LP, Polar Capital Holdings Plc, JPMORGAN CHASE & CO, Stonepine Capital Management, LLC, Rubric Capital Management LP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
168
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
182
Q2 2024 holders
167
Holder diff
-15
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.